PyInvesting

Market research

MRK Merck & Company Inc

NYSE USD Healthcare

Latest close

— —

Loading market data…

Test a moving-average rule with historical data.

Market cap
372B
P/E ratio
121.5
Analyst target
147.7692
Dividend yield
2.1%
Beta
0.21

Community

Investor discussion

10 comments

Admin profile picture
Admin

5 years, 4 months ago

Merck & Co., Inc is currently in a long term uptrend where the price is trading 5.0% above its 200 day moving average.

From a valuation standpoint, the stock is 99.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 4.1.

Merck & Co., Inc's total revenue rose by 5.5% to $13B since the same quarter in the previous year.

Its net income has dropped by 188.9% to $-2B since the same quarter in the previous year.

Finally, its free cash flow fell by 31.9% to $2B since the same quarter in the previous year.

Based on the above factors, Merck & Co., Inc gets an overall score of 3/5.

Fabienne profile picture
Fabienne

5 years, 7 months ago

$MRK This is you, right? (KEYTRUDA®) $IFRX
Young Guy profile picture
Young Guy

5 years, 7 months ago

$MRK Janey has $97 PT, that’s good enough for me. Im in at 79.
I.R.B profile picture
I.R.B

5 years, 7 months ago

$MRK There is a clue on the chart that it may go to 82.59 area
Bret O profile picture
Bret O

5 years, 7 months ago

Have some funds to spend after selling $ALXO and $MRK. Where are the buys at? Buying and looking to add more on $PTGX and $KNTE but would love to hear y'alls thoughts. Best of luck.
Dukesbro profile picture
Dukesbro

5 years, 7 months ago

$MRK anyone here about ivermectin and how it was taken by some senators to treat cv. Yet the public isn’t aware much. 🤔
I.R.B profile picture
I.R.B

5 years, 7 months ago

$MRK OK so it was red with market yesterday..What the f'ck is wrong today?
ThomasLD profile picture
ThomasLD

5 years, 7 months ago

$AUPH Good luck to all LUPUS PATIENTS from all over the 🌎. Your dream may come truth during the next 3 weeks because I believe that FDA will make a right decision to approve VOC since this is the best-in-class drug. AUPH has no debt, no convertible notes and has plenty of cash. Top buyers in 2021: $JNJ $PFE $SNY $MRK GL to all good investors in 2021💰🚀 AUPH is ready to lift off.
Sarah profile picture
Sarah

5 years, 7 months ago

$MRK buy the pull backs headed higher
RON profile picture
RON

5 years, 7 months ago

$ADXS Is a clinical-stage biotechnology company focused on the development and commercialization of immunotherapy products $MRK